Celltrion has internalized hyaluronidase-based SC formulation technology, enabling rapid drug administration and expanding its pipeline, with plans to seek regulatory approval for Herzuma SC and pursue CMO opportunities globally.
#YonhapInfomax #Celltrion #SCFormulation #Hyaluronidase #Herzuma #MarketShare #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=94407